Redmile Group’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Sell |
|
|||||
|
2025
Q1 | $1.86M | Sell |
|
|||||
|
2024
Q4 | $2.51M | Sell |
|
|||||
|
2024
Q3 | $6.68M | Hold |
|
|||||
|
2024
Q2 | $6.41M | Sell |
|
|||||
|
2024
Q1 | $9.5M | Sell |
|
|||||
|
2023
Q4 | $15.7M | Sell |
|
|||||
|
2023
Q3 | $29M | Sell |
|
|||||
|
2023
Q2 | $25.7M | Sell |
|
|||||
|
2023
Q1 | $24.9M | Sell |
|
|||||
|
2022
Q4 | $39.5M | Hold |
|
|||||
|
2022
Q3 | $32.6M | Sell |
|
|||||
|
2022
Q2 | $38.1M | Sell |
|
|||||
|
2022
Q1 | $38.9M | Sell |
|
|||||
|
2021
Q4 | $58.8M | Buy |
|
|||||
|
2021
Q3 | $67.4M | Sell |
|
|||||
|
2021
Q2 | $81.8M | Sell |
|
|||||
|
2021
Q1 | $81.8M | Buy |
|
|||||
|
2020
Q4 | $90.8M | Buy |
|
|||||
|
2020
Q3 | $74M | Buy |
|
|||||
|
2020
Q2 | $74M | Buy |
|